AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΏπΌ
LEVOFLOXACIN in Zimbabwe
4 products registered with MCAZ β 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| LEVIN - 500 TABLET, COATED; ORAL | 2015/7.2.5/5045 | HETERO LABS LTD | active | 8 Apr 2030 |
| LEVOMAC TABLET, COATED; ORAL | 2011/7.2.5/4710 | MACLEODS PHARMACEUTICALS LTD | active | 31 Dec 2027 |
| LEVOX TABLET; ORAL | 2015/7.2.5/4971 | VARICHEM PHARMACEUTICALS (PVT) LTD | active | 31 Dec 2027 |
| WELQUINE INJECTABLE; IV (INFUSION) | 2022/7.2.5/6263 | COSPHARM INVESTMENTS | active | 31 Dec 2027 |
LEVOFLOXACIN β MCAZ Registration Details
MCAZ (Zimbabwe) has 4 registered products containing LEVOFLOXACIN, of which 4 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track LEVOFLOXACIN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.